| Identification | Back Directory | [Name]
4,12-Dioxa-20-thia-21-azabicyclo[16.2.1]heneicosa-1(21),6,8,18-tetraene-5,13-dione,15-aMino-3-[(1E,3E,5E)-7-(diMethylaMino)-2,5-diMethyl-1,3,5-heptatrien-1-yl]-9,11,17-triMethyl-,(3S,6Z,8E,11S,15R,17S)- | [CAS]
139220-18-1 | [Synonyms]
(-)-pateamine
4,12-Dioxa-20-thia-21-azabicyclo[16.2.1]heneicosa-1(21),6,8,18-tetraene-5,13-dione,15-aMino-3-[(1E,3E,5E)-7-(diMethylaMino)-2,5-diMethyl-1,3,5-heptatrien-1-yl]-9,11,17-triMethyl-,(3S,6Z,8E,11S,15R,17S)- | [Molecular Formula]
C31H45N3O4S | [MOL File]
139220-18-1.mol | [Molecular Weight]
555.77 |
| Hazard Information | Back Directory | [Description]
Pateamine A is a marine macrolide that is isolated from the sponge Mycale hentscheli and exhibits anticancer and antiviral properties. It has a role as a marine metabolite, an antiviral agent, an antineoplastic agent, and a eukaryotic initiation factor 4F inhibitor. It is a macrolide, a member of 1,3-thiazoles, a tertiary amino compound, a primary amino compound, and an olefinic compound. Pateamine A an inhibitor of eukaryotic translation. | [Definition]
ChEBI: Pateamine is a marine macrodiolide that is isolated from the sponge Mycale hentscheli and exhibits anticancer and antiviral properties It has a role as a marine metabolite, an antiviral agent, an antineoplastic agent and a eukaryotic initiation factor 4F inhibitor. It is a member of 1,3-thiazoles, a tertiary amino compound, a primary amino compound, an olefinic compound and a macrodiolide. |
|
|